Concepedia
Statistics
Publications
123
Citations
15.8K
H-Index
65
Active since
1994
Affiliations
Novartis (United States)(Current)
Novartis (China)
Novartis (Switzerland)
Moffitt Cancer Center
Augusta University
Peter Atadja is an author at Novartis (United States) specializing in oncology, molecular oncology, and medicine.
Publications per year
1994–2023
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations
Medicine, Oncology, Pharmacology +12
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
Purva Bali, Michael Pranpat, James E. Bradner et al. · Journal of Biological Chemistry · 2005 · 749 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Lin Gao, Maria A. Cueto, Peter Atadja · Journal of Biological Chemistry · 2002 · 725 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +10
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi, Homan Chan, Lin Teng et al. · Proceedings of the National Academy of Sciences · 2012 · 545 citations · Full text
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra, Fengdong Cheng, Hongwei Wang et al. · Nature Immunology · 2008 · 454 citations
Life Sciences, Immunology, Molecular Biology +14
1–5 of 123